Cellens Inc

Sensing Cancer on a Nanoscale Level

Cellens Inc was founded in 2021, is headquartered in Boston, United States, lists 1–10 employees, and has $6.5M in recorded funding across 1 round.

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$6.5M
Last Round
$6.5M SeedDec 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.

About

Cellens is a Boston-based Tufts University spinout pioneering a non-invasive cancer diagnostics platform that uses nanoscale mechanobiology and machine learning to detect bladder cancer from urine samples. Its Octosense platform scans cell surfaces at nanoscale resolution to identify unique biophysical fingerprints of cancer cells. The company raised a $6.5M seed round in December 2025 to advance its AI-driven diagnostic technology.

Summary

Cellens Inc is a Biotech company based in Boston, United States, founded in 2021. It lists 1–10 employees. It has raised $6.5M in total across 1 round, most recently a $6.5M Seed round in Dec 2025. Investors include SOSV, American Cancer Society BrightEdge Fund and KOLON.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundDec 2025
$6.5M

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellens Inc on Indexed.vc
<a href="https://indexed.vc/companies/cellens-inc"><img src="https://indexed.vc/api/badge/company/cellens-inc" alt="Cellens Inc on Indexed.vc" width="260" height="76" /></a>